Fabtech Technologies IPO: Subscription Status and Details
The Fabtech Technologies Ltd.’s initial public offering (IPO) opened for subscription on Monday, September 29, with the aim of raising Rs 230.35 crore from the primary market. The IPO is a book-built issue that comprises entirely a fresh issue of 1.21 crore shares. The price band for the IPO is set between Rs 181 and Rs 191 per share.
The subscription window will be open from September 29 to October 1, with the allotment expected to be finalized on October 3. The company will transfer shares to the demat accounts of successful bidders on October 6, and refunds for non-allottees will be done on the same day.
IPO Subscription Status
As of 5:00 p.m. on Monday, the Fabtech Technologies IPO was subscribed 0.70 times or 70%. The subscription status is as follows:
- Institutional investors: 0.77 times
- Non-Institutional investors: 0.46 times
- Retail investors: 0.71 times
- Employee Reserved: 0.54 times
Grey Market Premium (GMP)
The latest grey market premium of Fabtech Technologies is Rs 2 as of 6:28 p.m. according to Investorgain.com. The stock’s estimated listing price is Rs 193, implying a gain of 1.05% over the IPO price of Rs 191.
Note: GMP does not represent official data and is based on speculation. GMP data sourced from InvestorGain.
Listing Details
The shares of the company are scheduled to list on the BSE and NSE on October 7. To participate in the IPO, retail investors need to bid for a single lot size of 75 shares, requiring an investment of Rs 14,325.
Small Non-Institutional Investors need to bid for 14 lots, amounting to an investment of Rs 2,00,550. Big Non-Institutional Investors can participate in the IPO by bidding for a minimum of 70 lots. It will lead to an investment of Rs 10,02,750.
Qualified Institutional Buyers (QIBs) will be offered a maximum of 50% of the net issue. Retail investors will be allocated a minimum of 35% of the net issue, and at least 15% will be reserved for Non-Institutional Investors.
About Fabtech Technologies
Fabtech Technologies is a biopharma engineering company. It provides engineering solutions to pharmaceutical, biotech, and healthcare companies.
The company will use proceeds from the IPO to fund working capital requirements, pursue inorganic growth, and for general corporate purposes.
Investor Participation
Unistone Capital Ltd. is the book running lead manager, and Bigshare Services Ltd. is the registrar for the issue.
To know more about the latest IPO news and stock market updates, visit our website.
